These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14762726)

  • 1. [Homocysteine: vascular risk factor?].
    Gil Núñez AC
    Neurologia; 2004; 19(1):1-4. PubMed ID: 14762726
    [No Abstract]   [Full Text] [Related]  

  • 2. [Risk factors for cardiovascular diseases: what is the role for homocysteine?].
    Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G
    G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic stroke and hyperhomocysteinemia: truth or myth?
    Terwecoren A; Steen E; Benoit D; Boon P; Hemelsoet D
    Acta Neurol Belg; 2009 Sep; 109(3):181-8. PubMed ID: 19902811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum total homocysteine levels and the prevalence of folic acid deficiency and C677T mutation at the MTHFR gene in an indigenous population of Amazonia: the relationship of homocysteine with other cardiovascular risk factors.
    Tavares EF; Vieira-Filho JP; Andriolo A; Perez AB; Vergani N; Sañudo A; Gimeno SG; Franco LJ
    Ethn Dis; 2004; 14(1):49-56. PubMed ID: 15002923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are homocysteine and MTHFR genotype polymorphism associated with arteriovenous fistula patency?
    Tai HC; Yang WC; Chen TW; Lin CC
    Am J Kidney Dis; 2005 Nov; 46(5):993-4; author reply 994. PubMed ID: 16253747
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data].
    Guilland JC; Favier A; Potier de Courcy G; Galan P; Hercberg S
    Pathol Biol (Paris); 2003 Mar; 51(2):101-10. PubMed ID: 12801808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
    Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC
    Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperhomocysteinemia and cardiovascular risk in diabetes mellitus].
    Russo GT; Cucinotta D
    Ann Ist Super Sanita; 2003; 39(2):153-63. PubMed ID: 14587213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-control Study of methylenetetrahydrofolate reductase mutations and hyperhomocysteinemia and risk of stroke.
    Almawi WY; Khan A; Al-Othman SS; Bakhiet M
    J Stroke Cerebrovasc Dis; 2009; 18(5):407-8. PubMed ID: 19717029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinemia: another independent vascular risk factor.
    Deleu D
    Saudi Med J; 2000 Aug; 21(8):787-8. PubMed ID: 11423902
    [No Abstract]   [Full Text] [Related]  

  • 11. [Homocysteine and rheumatic disease].
    Tinazzi I; Caramaschi P; Patuzzo G; Bambara LM; Biasi D
    Recenti Prog Med; 2007 Dec; 98(12):646-52. PubMed ID: 18369042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The plasma homocysteine, folic acid and vitamin B12 levels in young people with high risk for cardiovascular disease and its relation to metylentetrahydrofolate reductase (MTHFR) gene polymorphism].
    Klujber V; Lengyel B; Szabó T; Németh A; Dobó M
    Orv Hetil; 2005 Apr; 146(14):649-51. PubMed ID: 15889539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperhomocysteinemia, a risk factor for atherosclerosis: causes and effects].
    Weiss N; Pietrzik K; Keller C
    Dtsch Med Wochenschr; 1999 Sep; 124(38):1107-13. PubMed ID: 10535040
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of homocysteine, vitamin B12, folic acid, and MTHFR C677T in patients with a thrombotic event or recurrent fetal loss.
    Nadir Y; Hoffman R; Brenner B
    Ann Hematol; 2007 Jan; 86(1):35-40. PubMed ID: 17043779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylenetetrahydrofolate reductase gene polymorphism and childhood stroke.
    Morita DC; Donaldson A; Butterfield RJ; Benedict SL; Bale JF
    Pediatr Neurol; 2009 Oct; 41(4):247-9. PubMed ID: 19748043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic determinants of plasma total homocysteine.
    Gellekink H; den Heijer M; Heil SG; Blom HJ
    Semin Vasc Med; 2005 May; 5(2):98-109. PubMed ID: 16047263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinemia: clinical and therapeutical involvement in venous thrombosis.
    Hoţoleanu C; Porojan-Iuga M; Rusu ML; Andercou A
    Rom J Intern Med; 2007; 45(2):159-64. PubMed ID: 18333369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging risk factors for ischemic stroke.
    Abbate R; Sofi F; Brogi D; Marcucci R
    Neurol Sci; 2003 May; 24 Suppl 1():S11-2. PubMed ID: 12774202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine, folate, and congenital heart defects.
    Huhta JC; Hernandez-Robles JA
    Fetal Pediatr Pathol; 2005; 24(2):71-9. PubMed ID: 16243751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.